Skip to content
DraconiticResearch
Search Sources API
203,948 studies31 sourcesUpdated 27 min ago
Peer-reviewedCC BY-NC 4.0The European Journal of Public Health

Enhancing the Salience of Future Health Risks to Promote Smoking Cessation: A Randomized Nudge Trial

Abstract

Background: Present bias, a central concept in behavioral economics, offers a useful framework for understanding why smokers often prioritize the immediate rewards of smoking over its long-term health consequences. We examined whether personalized disease-risk prediction information derived from health examination results could serve as a nudge-based intervention to reduce present bias and improve smoking cessation outcomes.

Methods: The study included 367 heavy smokers with a smoking history of at least 20 pack-years who were enrolled in a residential smoking cessation camp at a Regional Tobacco Control Centre in Cheongju, Korea, from 2021 to 2024. Participants were randomly assigned to receive either an AI-driven personalized report estimating their 4-year risks of developing nine major diseases (n = 171, 46.6%) or no report (n = 196, 53.4%). Smoking cessation was assessed through week 24.

Results: Although cessation rates declined over time in both groups, they remained higher in the intervention group, with the largest between-group difference observed at week 12 (82.5% vs. 64.8%, p < 0.001). The between-group difference remained significant through week 18 but was not significant thereafter in the overall sample. In subgroup analyses, a significant difference persisted through week 24 only among participants aged <65 years (p = 0.035). In fully adjusted logistic regression models, the intervention was associated with higher odds of smoking cessation at week 12 (OR = 2.49, 95% CI, 1.47–4.21) and week 16 (OR = 1.74, 95% CI, 1.08–2.77). Perceived importance of quitting and cessation self-efficacy were also higher in the intervention group.

Conclusions: These findings suggest that personalized disease-risk prediction information may support smoking cessation by increasing smokers’ perceived susceptibility to smoking-related diseases and the salience of future health consequences, thereby shifting their decisional balance toward quitting.

Key messages: • Among heavy smokers who intended to quit, a personalized disease-risk prediction report was associated with significantly higher short- to mid-term smoking cessation success than in the control group.

• Personalized disease-risk information may promote quitting by increasing the salience of future health consequences, enhancing perceived susceptibility, and helping counteract present bias.

Related

  1. Actívatexto: Advancing Smoking Cessation and Physical Activity among Latino Adults. Study Protocol for a Randomized Clinical Trial
    Jeffrey W. Ramos Santiago, Rafael H. Orfin, Daimarelys Lara +15
    Contemporary clinical trialsPeer-reviewedLicence not statedFull textPhysiologyPMC
  2. Adapting and implementing very brief advice+ (VBA+) in primary care to promote adolescent smoking cessation in Kyrgyzstan: A mixed-methods FRESHAIR4Life study.
    Julia M van Koeveringe, Gulzada Mirzalieva, Aijan Taalaibekova +11
    Tobacco prevention & cessationPeer-reviewedCC BYFull textPhysiologyEurope PMC
  3. A Randomized Factorial Trial of Varenicline, Nicotine Lozenges, and Smartphone Medication Adherence Reminders for Smoking Cessation: Protocol for the COMBO II Study.
    Nathalia M Machado, Jasjit S Ahluwalia, Michael S Businelle +11
    JMIR research protocolsPeer-reviewedCC BYFull textPhysiologyEurope PMCPMC
  4. Remote vs. In-Person Study Evaluation (RISE) Trial 1 of 3 to examine the impact of decentralized trial methods on accrual efficiency, retention, biospecimen capture, and treatment utilization: study protocol for a multi-center randomized controlled trial in the context of smoking cessation (RISE Above Smoking)
    Larry W. Hawk, Robert A. Schnoll, Jennifer Dahne +10
    TrialsPeer-reviewedCC BY-NC-ND 4.0Full textEpidemiology & public healthPMC
  5. An analysis of enrollment rates by admitting service for a secondary analysis of enrollment data from a randomized smoking-cessation trial (FIESTA)
    Kayla Koffler, Michelle He, Joseph A. Ladapo +1
    PLOS OnePeer-reviewedCC0Full textEcologyPsychiatry & mental healthPLOSPMC
BibTeX
@article{park2026enhancing,
  title = {{Enhancing the Salience of Future Health Risks to Promote Smoking Cessation: A Randomized Nudge Trial}},
  author = {JE Park and SH Park and JH Park and SY Kim and HJ Kim},
  journal = {The European Journal of Public Health},
  year = {2026},
  month = oct,
  doi = {10.1093/eurpub/ckag169.329},
  url = {https://doi.org/10.1093/eurpub/ckag169.329},
  note = {CC BY-NC 4.0},
}
RIS
TY  - JOUR
TI  - Enhancing the Salience of Future Health Risks to Promote Smoking Cessation: A Randomized Nudge Trial
AU  - JE Park
AU  - SH Park
AU  - JH Park
AU  - SY Kim
AU  - HJ Kim
PY  - 2026
DA  - 2026/10/01
JO  - The European Journal of Public Health
DO  - 10.1093/eurpub/ckag169.329
UR  - https://doi.org/10.1093/eurpub/ckag169.329
AB  - Background: Present bias, a central concept in behavioral economics, offers a useful framework for understanding why smokers often prioritize the immediate rewards of smoking over its long-term health consequences. We examined whether personalized disease-risk prediction information derived from health examination results could serve as a nudge-based intervention to reduce present bias and improve smoking cessation outcomes.  Methods: The study included 367 heavy smokers with a smoking history of at least 20 pack-years who were enrolled in a residential smoking cessation camp at a Regional Tobacco Control Centre in Cheongju, Korea, from 2021 to 2024. Participants were randomly assigned to receive either an AI-driven personalized report estimating their 4-year risks of developing nine major diseases (n = 171, 46.6%) or no report (n = 196, 53.4%). Smoking cessation was assessed through week 24.  Results: Although cessation rates declined over time in both groups, they remained higher in the intervention group, with the largest between-group difference observed at week 12 (82.5% vs. 64.8%, p < 0.001). The between-group difference remained significant through week 18 but was not significant thereafter in the overall sample. In subgroup analyses, a significant difference persisted through week 24 only among participants aged <65 years (p = 0.035). In fully adjusted logistic regression models, the intervention was associated with higher odds of smoking cessation at week 12 (OR = 2.49, 95% CI, 1.47–4.21) and week 16 (OR = 1.74, 95% CI, 1.08–2.77). Perceived importance of quitting and cessation self-efficacy were also higher in the intervention group.  Conclusions: These findings suggest that personalized disease-risk prediction information may support smoking cessation by increasing smokers’ perceived susceptibility to smoking-related diseases and the salience of future health consequences, thereby shifting their decisional balance toward quitting.  Key messages: • Among heavy smokers who intended to quit, a personalized disease-risk prediction report was associated with significantly higher short- to mid-term smoking cessation success than in the control group.  • Personalized disease-risk information may promote quitting by increasing the salience of future health consequences, enhancing perceived susceptibility, and helping counteract present bias.
SN  - 1101-1262
SN  - 1464-360X
ER  -